In the context of intestinal inflammation, CD4+ CTLs are enriched in intestinal biopsies of patients with IBD compared with those of healthy controls [15–18] and in mice with colitis induced by naïve T cells [19, 42, 43], but the related studies have mostly relied on analyses of the expression of phenotypic surface markers. The gene discussed is CD4; the disease is inflammatory bowel disease.